ES2072447T3 - Locion analgesica externa y procedimiento de preparacion. - Google Patents

Locion analgesica externa y procedimiento de preparacion.

Info

Publication number
ES2072447T3
ES2072447T3 ES90913658T ES90913658T ES2072447T3 ES 2072447 T3 ES2072447 T3 ES 2072447T3 ES 90913658 T ES90913658 T ES 90913658T ES 90913658 T ES90913658 T ES 90913658T ES 2072447 T3 ES2072447 T3 ES 2072447T3
Authority
ES
Spain
Prior art keywords
preparation procedure
external analgesic
analgesic lotion
lotion
external
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913658T
Other languages
English (en)
Inventor
Jeffery W Ivy
Curtis E Payne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2072447T3 publication Critical patent/ES2072447T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA LOCION ANALGESICA EXTERNA CONTENIENDO INGREDIENTES ACTIVOS DE SILICIALATO DE METIL Y CAMFOR Y MENTOL PARA ALIVIAR EL DOLOR EN MUSCULOS, ARTICULACIONES O CUALQUIER OTRO ORGANO, EN EL SITIO DE APLICACION POR LA ESTIMULACION DE RECEPTORES SENSORIALES CUTANEOS Y UN METODO DE HACER DICHA LOCION Y HACIENDOLA DE CAMFOR Y CRISTALES DE MENTOL.
ES90913658T 1989-09-12 1990-08-29 Locion analgesica externa y procedimiento de preparacion. Expired - Lifetime ES2072447T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/406,072 US5013726A (en) 1989-09-12 1989-09-12 External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion

Publications (1)

Publication Number Publication Date
ES2072447T3 true ES2072447T3 (es) 1995-07-16

Family

ID=23606433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913658T Expired - Lifetime ES2072447T3 (es) 1989-09-12 1990-08-29 Locion analgesica externa y procedimiento de preparacion.

Country Status (9)

Country Link
US (1) US5013726A (es)
EP (1) EP0443007B1 (es)
AT (1) ATE119386T1 (es)
CA (1) CA2025078C (es)
DE (1) DE69017654T2 (es)
DK (1) DK0443007T3 (es)
ES (1) ES2072447T3 (es)
HK (1) HK48897A (es)
WO (1) WO1991004010A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118240C2 (de) * 1991-06-04 1997-08-14 Marianne Seiler Tonisierendes Mittel
US5223257A (en) * 1992-03-11 1993-06-29 Vasu Arora Topical composition for relieving aches and pains
US5446025A (en) * 1992-06-12 1995-08-29 Abbott Laboratories Formulations and method of the percutaneous administration of leuprolide
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition
ES2191664T5 (es) * 1992-07-13 2008-02-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
US5888984A (en) 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
UA10208A (uk) * 1994-08-03 1996-12-25 Жанна Прокопівна Гудзенко Дерматологічний косметичний засіб
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
WO1998034628A1 (en) * 1997-02-05 1998-08-13 Au Pharmaceuticals, Inc. Composition for the treatment of haemorrhoids and other anorectal inflammations
US6572871B1 (en) * 1999-01-06 2003-06-03 W. Edward Church Pain treatment method and apparatus using heating wrap and analgesic cream
US20040073258A1 (en) * 1999-01-06 2004-04-15 Church W. Edward Body tissue and skin treatment method using pulsing heating pad and topical cream
WO2000042848A1 (en) * 1999-01-19 2000-07-27 Bj Farmacéutica Ltda. Medicinal composition and its process of preparation
DE60034667T2 (de) 1999-02-01 2008-03-13 Dermal Research Laboratories, Inc. Pharmazeutische zusammensetzung aus komplexen kohlenhydraten und deren anwendung
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US8900607B1 (en) 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US7138394B2 (en) 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
ES2620672T3 (es) 2008-01-09 2017-06-29 Charleston Laboratories, Inc. Comprimidos de doble capa que comprenden oxicodona y prometazina
SG173832A1 (en) * 2009-02-24 2011-09-29 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
EP2429559A4 (en) * 2009-05-08 2013-08-14 Allmedic Pty Ltd TREATMENT OF PAIN AND / OR INFLAMMATION AS WELL AS TREATMENT AND PREVENTION OF SKIN OR SLICING DISEASES OR TROUBLES
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2025064645A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating inflammatory bowel disease
WO2025064621A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating colorectal cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644620A (en) * 1970-05-22 1972-02-22 William J Vittone Antiphlogistic
FR2184525A2 (en) * 1972-05-19 1973-12-28 Sotil Marie Lou Se Skin treatment compsn - contg particles of pure gold and vegetable animal mineral matl
DE3009143A1 (de) * 1980-03-10 1981-10-01 Hans Dr Bauersfeld Arzneimittelzubereitung und deren verwendung
US4784849A (en) * 1983-08-15 1988-11-15 Tutsky Ronald J Skin care and shaving compositions
HUT37342A (en) * 1983-10-17 1985-12-28 Caola Kozmetikai Process for production of preparatives for medical cosmetics
FR2554715B1 (fr) * 1983-11-10 1987-07-24 Roullier Anne Gamme de produits cosmetiques contenant des particules de poudre d'or
US4657763A (en) * 1985-09-03 1987-04-14 Michael Ebert Combined chrysotherapeutic agents for autoimmune diseases
US4725438A (en) * 1986-05-29 1988-02-16 Leazer Billie S Aloe vera ointment
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US4883664A (en) * 1987-06-29 1989-11-28 Mary Sharkey Medicinal salve

Also Published As

Publication number Publication date
EP0443007A1 (en) 1991-08-28
EP0443007A4 (en) 1993-03-03
WO1991004010A1 (en) 1991-04-04
DE69017654T2 (de) 1996-01-18
CA2025078A1 (en) 1991-03-13
HK48897A (en) 1997-04-25
CA2025078C (en) 1996-01-30
DE69017654D1 (de) 1995-04-13
US5013726A (en) 1991-05-07
ATE119386T1 (de) 1995-03-15
EP0443007B1 (en) 1995-03-08
DK0443007T3 (da) 1995-05-22

Similar Documents

Publication Publication Date Title
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
NO153637C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat som er egnet for transdermal administrering av virkestoffer.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ES2001391A6 (es) Procedimiento de obtencion de una composicion farmaceutica para el tratamiento de senos faciales y nasales, alergias y sintomas de resfriado.
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
ATE64297T1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
MY132705A (en) Novel compounds with analgesic effect
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
MX171191B (es) Composiciones farmaceuticas de glipizida
ES2160712T3 (es) Nueva preparacion farmaceutica para tratamiento del dolor.
CO5261517A1 (es) Composiciones farmaceuticas analgesicas que contienen buprenorfina/naloxona, buprenorfina/naltrexona o buprenorfina/nalmefen en bajas dosis
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ATE15596T1 (de) Pharmazeutische mittel.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
AR025030A1 (es) Utilizacion de flupirtina para aliviar los dolores en las artropatias degenerativas en perros y gatos para la preparacion de un medicamento para eltratamiento de dichas afecciones
IT1204777B (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico
AR017176A1 (es) Nueva formulacion para el uso en el manejo del dolor.
SE8902458L (sv) Laekemedelskomposition
KR890007728A (ko) 진통제 제조방법
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 443007

Country of ref document: ES